Celltrion Stock Price at 344,000 Won... Down 4.18% from Previous Day
As of 12:32 PM on the 4th, Celltrion is trading at 344,000 KRW, down 4.18% from the previous day. This represents a 14.75% decrease compared to December 7. Celltrion is known as a manufacturer of protein and biopharmaceutical products.
Today, foreigners have net sold 33,000 shares of Celltrion, and institutions have net sold 32,000 shares, according to provisional data. Over the past five days, individual investors have net sold 310,135 shares, while foreigners and institutions have net bought 332,749 shares and net sold 5,955 shares, respectively.
On December 29, Celltrion was in the spotlight in the market for completing the global Phase 2 clinical trial of the COVID-19 antibody treatment CT-P59.


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.